Stroke in a neonate heterozygous for factor V Leiden. (Q54140056)

25 May 2018

title

Stroke in a neonate heterozygous for factor V Leiden. (English)

1 reference

25 May 2018

1 reference

Varelas PN

1

1 reference

25 May 2018

Sleight BJ

2

1 reference

25 May 2018

Rinder HM

3

1 reference

25 May 2018

Sze G

4

1 reference

25 May 2018

Ment LR

5

1 reference

25 May 2018

publication date

1 March 1998

1 reference

25 May 2018

published in

Pediatric Neurology

1 reference

25 May 2018

volume

18

1 reference

25 May 2018

issue

3

1 reference

25 May 2018

page(s)

262-264

1 reference

25 May 2018

Cerebral infarcts with arterial occlusion in neonates

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900166-5

7 January 2021

Perinatal cerebral infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900166-5

7 January 2021

MRI in neonatal dural sinus thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900166-5

7 January 2021

Children with cerebral venous thrombosis diagnosed with magnetic resonance imaging and magnetic resonance angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900166-5

7 January 2021

Neonatal idiopathic cerebral venous thrombosis: an unrecognized cause of transient seizures or lethargy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900166-5

7 January 2021

Mutation in blood coagulation factor V associated with resistance to activated protein C.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900166-5

7 January 2021

Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900166-5

7 January 2021

The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900166-5

7 January 2021

Arterial and venous thrombosis in two Italian families with the factor V Arg506-->Gln mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900166-5

7 January 2021

Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900166-5

7 January 2021

Activated protein C resistance in ischemic stroke not due to factor V arginine506-->glutamine mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900166-5

7 January 2021

Evaluation of a tissue factor dependent factor V assay to detect factor V Leiden: demonstration of high sensitivity and specificity for a generally applicable assay for activated protein C resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900166-5

7 January 2021

Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900166-5

7 January 2021

Activated protein C resistance in a neonate with venous thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900166-5

7 January 2021

The Risk of Recurrent Venous Thromboembolism in Patients with an Arg506→Gln Mutation in the Gene for Factor V (Factor V Leiden)

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2897%2900166-5

7 January 2021

10.1016/S0887-8994(97)00166-5

Identifiers

DOI

1 reference

25 May 2018

1 reference

25 May 2018